68 Ga-DOTA-IBA Uptake in Meningioma and Liver Metastasis of Breast Cancer.

IF 9.6 3区医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING

Clinical Nuclear Medicine Pub Date : 2025-08-01 Epub Date: 2025-05-20 DOI:10.1097/RLU.0000000000005890

Haoyuan Ding, Juan Liang, Lin Chen, Jiqing Xuan, Yue Chen

引用次数: 0

Abstract

A 41-year-old woman with bone and liver metastasis of breast cancer was enrolled in our 68 Ga-labeled DOTA-ibandronic acid ( 68 Ga-DOTA-IBA) PET/CT tumor clinical trial. The examination revealed increased uptake of 68 Ga-DOTA-IBA in the multiple bone metastases. Unexpectedly, 68 Ga-DOTA-IBA uptake in meningioma and liver metastasis were also noted.

查看原文本刊更多论文

乳腺癌脑膜瘤中ga - dota - iba摄取与肝转移的关系。

我们的68ga标记的dota -iba (68Ga-DOTA-IBA) PET/CT肿瘤临床试验纳入了一名41岁的乳腺癌骨和肝转移患者。检查显示多发骨转移灶中68Ga-DOTA-IBA摄取增加。出乎意料的是，在脑膜瘤和肝转移中也发现了68Ga-DOTA-IBA的摄取。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Clinical Nuclear Medicine 医学-核医学

CiteScore

2.90

自引率

31.10%

发文量

1113

审稿时长

2 months

期刊介绍： Clinical Nuclear Medicine is a comprehensive and current resource for professionals in the field of nuclear medicine. It caters to both generalists and specialists, offering valuable insights on how to effectively apply nuclear medicine techniques in various clinical scenarios. With a focus on timely dissemination of information, this journal covers the latest developments that impact all aspects of the specialty. Geared towards practitioners, Clinical Nuclear Medicine is the ultimate practice-oriented publication in the field of nuclear imaging. Its informative articles are complemented by numerous illustrations that demonstrate how physicians can seamlessly integrate the knowledge gained into their everyday practice.